Skip to main content
Clinical Trials/NCT02642731
NCT02642731CompletedNot Applicable

Kidney Biomarkers of Acute Kidney Injury in Patients With Knee Arthroplasty- a Pilot Study

Kuopio University Hospital1 site in 1 country30 target enrollmentStarted: September 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Renal function

Study Overview

Brief Summary

Sensitive renal markers have been studied abundantly in connection with open heart, liver and transplantation surgery; however in major orthopaedic surgery their use is anecdotal. The aim of the present study is to evaluate use of sensitive renal markers, NGAL (Neutrophil gelatinase associated lipocalin ), KIM-1 (Kidney injury molecule- 1), LFABP (liver-type fatty acid-binding protein), and IL-18 (interleukin -18), in patients coming for elective TKA (total knee arthroplasty) as a pilot study before large study concerning acute kidney injury in orthopaedic surgery.

Detailed Description

Acute renal deterioration is a serious adverse event in elective surgery. Serum creatinine based diagnostics of acute kidney injury may delay diagnosis and produce false negative results since serum creatinine is affected by diet, muscle mass, used hydration therapy. In recent times new markers have been developed and tested in order to find sensitive, fast and reliable marker of renal deterioration.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
50 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • informed consent
  • allergy to NSAIDs

Exclusion Criteria

  • no informed consent

Outcomes

Primary Outcomes

Renal function

Time Frame: time zero hours to 48 hours

S-creatinine, Cystatin C, estimated GFR

Secondary Outcomes

  • Concentraton of sensitive renal markers(time zero hours to 24 hours)

Investigators

Sponsor
Kuopio University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Merja Kokki

MD, PhD

Kuopio University Hospital

Study Sites (1)

Loading locations...

Similar Trials